Provectus Biopharmaceuticals Receives Notice of Allowance for Adult Solid Tumor Cancer Combination Therapy Patent for PV-10(R) Immunotherapy from United States Patent and Trademark Office

Source :: GlobeNewswire. March 30, 2021
Publication Year :: 2021
Abstract: KNOXVILLE, TN, Mar 30, 2021 (GLOBE NEWSWIRE via COMTEX) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent (USP) application [...]

Subjects :: Biopharmaceutics -- Forecasts and trends -- Intellectual property
Prostate cancer -- Development and progression
Trademarks -- Forecasts and trends
Ipilimumab -- Forecasts and trends
Immunotherapy -- Forecasts and trends
Cancer -- Care and treatment
Lung cancer, Non-small cell -- Development and progression
Liver cancer -- Development and progression
Melanoma -- Development and progression
Market trend/market analysis
Banking, finance and accounting industries
Business

Tools